Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Oil Fund LP
USO
5
ProShares Ultra Energy
DIG
US Stock MarketDetailed Quotes
Nymox Pharmaceutical (NYMXF)
- 0.0101
- +0.0001+1.00%
15min DelayClose Jul 24 13:22 ET
954.86KMarket Cap-0.20P/E (TTM)
0.0120High0.0101Low103.00KVolume0.0120Open0.0100Prev Close1.19KTurnover0.18%Turnover RatioLossP/E (Static)94.54MShares0.199952wk High-0.14P/B585.07KFloat Cap0.005652wk Low--Dividend TTM57.93MShs Float13.6250Historical High--Div Yield TTM19.00%Range %0.0001Historical Low0.0115Avg Price1Lot Size
Nymox Pharmaceutical (NYMXF) Key Financial Indicators
NYMXF Earnings per Share (EPS)
According to the latest financial report of Nymox Pharmaceutical, the latest earnings per share (TTM) for the company is -0.01. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
NYMXF Free Cash Flow (FCF)
Interested in knowing about Nymox Pharmaceutical's free cash flow? The latest report shows it as -717.00K. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
NYMXF Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Nymox Pharmaceutical shows that the company's current ratio is 0.09, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
NYMXF Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Nymox Pharmaceutical, the quick ratio is 0.01, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
NYMXF Return on Equity (ROE)
Want to learn more about the financial health of Nymox Pharmaceutical? The latest ROE figure is -920.27%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
NYMXF Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Nymox Pharmaceutical, the total asset return on investment (ROA) is -134.12%.
Currency: USD
Quarterly
Loading...
NYMXF Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Nymox Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 100.00%.
Currency: USD
Quarterly
Loading...
NYMXF Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Nymox Pharmaceutical, the net profit margin is 106.22K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Signs of de-escalation in U.S.-Iran military tensions have emerged, pushing international oil prices lower. Trump ordered the U.S. military
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm